HBP Surgery Week 2025

Details

[BP Oral Presentation 1 - Biliary & Pancreas (Other (ERAS, Education, Etc.))]

[BP OP 1-3] HOW DO WE ASESS THE OPERATIVE RISK OF HEPATOBILIARY-PANCREAS SURGERY IN ELDERLY PATIENTS: RETROSPECTIVE ANALYSIS USING COMPREHENSIVE FRAILTY ASESSMENT
Mirang LEE 1, Ji Yeon BAEK 2, Jin Ju KIM 1, Minkyu SUNG 1, Kwang Pyo HONG 1, Woohyung LEE 1, Ki Byung SONG 1, Jae Hoon LEE 1, Song Cheol KIM 1, Dae Wook HWANG 1
1 Division of Hepatobiliary And Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan, Korea, 2 Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan, Korea

Background : In an aging society, as the age of patients undergoing hepatobiliary-pancreas surgery increases. Frailty, as a biological age, is an independent prognostic factor for postoperative morbidity and mortality. This study aims to investigate the impact of frailty on the occurrence of postoperative complications in hepatobiliary-pancreas surgery.

Methods : From June 2021 to April 2024, we retrospectively analyzed 188 patients who underwent comprehensive frailty assessment among patients who underwent hepatobiliary-pancreas surgery at Asan Medical Center. Demographics, clinicopathologic, and surgical data were retrieved for analysis.

Results : Frail patients with a 50-item frailty index (FI) greater than 0.15 had higher 90-day mortality (10.6% vs. 2.5%, p = 0.042) compared to robust patients. Other perioperative outcomes were not significantly different. In logistic regression, FI of 0.15 was an independent predictor of 90-day mortality (OR 11.42, p = 0.008), along with operation type.

Conclusions : Despite similar complication rates, the recovery capacity after the same surgery appears to differ depending on frailty. Therefore, patients with a 50-item FI greater than 0.15 should be carefully considered before undergoing hepatobiliary-pancreatic surgery, as they are likely to experience high morbidity. Incorporating frailty assessments into preoperative planning may optimize care for high-risk patients.



HBP 2025_OP_0222.pdf
SESSION
BP Oral Presentation 1
Room 2 3/27/2025 3:30 PM - 4:30 PM